Direct to Implant Reconstruction
Clinics in Plastic Surgery · 2023
DOI: 10.1016/j.cps.2022.11.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Plastic Surgery, 2023. Verfasst von Jordan M S Jacobs und 1 weiteren Autor:innen. Beteiligte Einrichtung: Icahn School of Medicine, Mount Sinai Hospital, 1 Gustave Levy Place, New York, NY 10029, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Breast Implants, Breast Implantation, Acellular Dermis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Implant-based breast reconstruction remains the most commonly performed type of restorative surgery after mastectomy for breast cancer. Placement of a tissue expander at the time of mastectomy allows gradual skin envelope expansion but requires additional surgery and time to completion of a patient's reconstruction. Direct-to-implant reconstruction provides a one-stage, final implant insertion, thereby bypassing the need for serial tissue expansion. With proper patient selection, successful preservation of the breast skin envelope, and accurate implant size and placement, direct-to-implant reconstruction has a very high rate of success and patient satisfaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Icahn School of Medicine, Mount Sinai Hospital, 1 Gustave Levy Place, New York, NY 10029, USA.
- Cleveland Clinic Florida, 3555 10th Ct, Vero Beach, Fl 32960, USA. Electronic address: asalzbergmd@yahoo.com.
Zitieren
APA
Jacobs, J. M. S., & Salzberg, C. A. (2023). Direct to Implant Reconstruction. Clinics in Plastic Surgery. https://doi.org/10.1016/j.cps.2022.11.003
Vancouver
Jacobs JMS, Salzberg CA. Direct to Implant Reconstruction. Clinics in Plastic Surgery. 2023. doi:10.1016/j.cps.2022.11.003
BibTeX
@article{Jacobs2023,
author = {Jacobs, Jordan M S and Salzberg, Charles Andrew},
title = {Direct to Implant Reconstruction},
journal = {Clinics in Plastic Surgery},
year = {2023},
doi = {10.1016/j.cps.2022.11.003}
}
EUVIMED